Article
Prognostic value of genomic damage in non-small-cell lung cancer.
British journal of cancer - 1 Jun 1998
de Juan C, Iniesta P, Vega F J, Peinado M A, Fernandez C, Caldés T, Massa M J, López J A, Sánchez A, Torres A J, Balibrea J L, Benito M
Abstract excerpt
Genomic alterations have been analysed in 65 non-small-cell lung cancer (NSCLC) tissue samples by using the arbitrarily primed polymerase chain reaction (AP-PCR), which is a PCR-based genomic fingerprinting. We have shown that AP-PCR may be applied as a useful and feasible practical method for detection of the genomic alterations that accompany malignancy in NSCLC. Genomic changes detected by us consisted of:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
